Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wedbush Maintains Neutral on Biogen, Raises Price Target to $217

Wedbush analyst Laura Chico maintains Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $183 to $217.
byBenzinga Newsdesk
September 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Wedbush analyst Laura Chico maintains Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $183 to $217.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0